My watch list
my.bionity.com  
Login  

39 Current news about the topic project management

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

Affimed Appoints Dr. Wolfgang Fischer as Chief Operating Officer

14-Sep-2017

Affimed N.V. announced the appointment of Dr. Wolfgang Fischer as Chief Operating Officer. "We are very pleased that Dr. Wolfgang Fischer has joined our management team as COO," said Dr. Adi Hoess, Chief Executive Officer of Affimed. "With his solid track record in drug development and project ...

more

Open Source Innovation Is Increasingly Being Used to Promote Innovation in the Drug Discovery Process and Boost Bottom Lines

23-Nov-2010

The completion of the human genome project generated a plethora of complex information that launched the medical community into the next era of therapeutic intervention. New discoveries have led to the need for new ways to tap the vast amounts of information, so as to optimise its potential use. ...

more

TranScrip Partners expands further with two new senior appointments

Julia Lloyd-Parks and Mark Watling join the organisation as Senior Partners

23-Nov-2010

TranScrip Partners LLP announced the appointment of two new senior partners, Julia Lloyd-Parks and Mark Watling. The move is set to further enhance the organisation’s high level expertise in clinical research, clinical development and medical affairs across multiple therapeutic areas. This ...

more

CARDIALYSIS And Sticares InterACT Announce Strategic Collaboration

29-Sep-2010

Cardialysis and Sticares InterACT, both Contract Research Organizations (CROs) headquartered in The Netherlands, announced that they have entered into a strategic collaboration to provide drug development consulting services in the field of cardiovascular and metabolic medicine. Both ...

more

University of Florida launches unique translational biotechnology master’s program

03-Sep-2010

The University of Florida College of Medicine in collaboration with UF’s Warrington College of Business Administration has started a two-year master’s program in translational biotechnology that will prepare graduates for management roles in industry and academia by equipping them with knowledge ...

more

Dr. August Wolff Arzneimittel GmbH & Co. KG and Mercachem B.V. start two drug development collaborations

30-Aug-2010

Dr. August Wolff GmbH & Co. KG Arzneimittel and Mercachem have started two multi-year drug development collaborations. Dr. August Wolff GmbH & Co. KG Arzneimittel have licensed a number of patents from universities that cover novel classes of molecules with potential use in dermatology. Mercachem ...

more

CT Atlantic AG Announces Appointment of Michael Höcker to CEO

Cara Lerner joins CT Atlantic as COO

30-Jul-2010

CT Atlantic AG, a biotechnology company focused on cancer treatment by human-derived antibodies, announced the appointment of Michael Höcker to CEO. In addition, Cara Lerner has been appointed to COO. Michael Höcker most recently served as a Global Medical Director at Hoffmann-La Roche Ltd. ...

more

Starting of the European project REBORNE aiming at bone defects regeneration using stem cells and biomaterials

10-Jun-2010

Submitted by the end of 2008, the project REBORNE for 'Regenerating Bone defects using New biomedical Engineering approaches' has been accepted by the European Commission in the thematic area Health of the 7th Framework Program. Coordinated by Inserm supported by Alcimed for the project ...

more

Upgrade to Advanced Photon Source announced by DOE: First phase of planning and development approved

05-May-2010

Advances in energy conservation, better materials for frontier technologies and new economic engines, and breakthroughs in understanding diseases: These are just a few of the potential discoveries, both basic and applied, to be enabled by an upgrade to the Advanced Photon Source (APS) at the U.S. ...

more

Biocitech technology park appoints Jean-François Boussard as CEO

09-Mar-2010

Biocitech SAS announced that its board has appointed Jean-François Boussard as CEO with effect from April 1st. Jean-François Boussard replaces Jacques Lhomel, who is taking retirement to pursue a number of personal projects. Jean-François Boussard, 58, joins Biocitech after a long and successful ...

more

Page 1 From 4
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE